Orthofix Medical Inc. Restricted Cash and Cash Equivalents, Current
Orthofix Medical Inc. (OFIX) had Restricted Cash and Cash Equivalents, Current of $505.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-05.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue · last filed 2022-02-25
- 2021-09-30: Restricted Cash and Cash Equivalents, Current $505.00K.
- 2021-06-30: Restricted Cash and Cash Equivalents, Current $554.00K.
- 2021-03-31: Restricted Cash and Cash Equivalents, Current $488.00K.
- 2020-12-31: Restricted Cash and Cash Equivalents, Current $530.00K.
| Period end | Restricted Cash and Cash Equivalents, Current | Restricted Cash and Cash Equivalents, Current as first filed |
|---|---|---|
| 2021-09-30 | $505.00K 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $554.00K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $488.00K 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $530.00K 10-K · filed 2022-02-25 | |
| 2020-09-30 | $490.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $503.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $529.00K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $684.00K 10-K · filed 2021-02-26 | |
| 2019-09-30 | $654.00K 10-Q · filed 2019-10-28 | |
| 2019-03-31 | $2.54M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $2.57M 10-K · filed 2020-02-24 | |
| 2018-09-30 | $2.46M 10-Q · filed 2018-10-29 | |
| 2016-12-31 | $14.37M 10-K · filed 2018-02-26 | |
| 2015-03-31 | $27.25M 10-Q · filed 2015-05-18 | |
| 2014-12-31 | $34.42M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $34.63M 10-Q · filed 2015-03-31 | |
| 2014-06-30 | $45.25M 10-Q · filed 2015-03-31 | |
| 2014-03-31 | $19.27M 10-Q/A · filed 2015-03-31 | |
| 2013-12-31 | $23.76M 10-K · filed 2015-04-29 | |
| 2013-09-30 | $22.73M 10-Q · filed 2014-03-25 | |
| 2013-06-30 | $20.60M 10-Q · filed 2014-03-24 | |
| 2013-03-31 | $29.45M 10-Q/A · filed 2014-03-24 | |
| 2012-12-31 | $21.31M 10-K/A · filed 2015-03-31 | |
| 2012-09-30 | $67.32M 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $72.91M 10-Q · filed 2012-07-30 | |
| 2012-03-31 | $79.37M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $45.48M 10-K/A · filed 2014-03-24 | $47.10M 10-K · filed 2012-02-29 |
| 2011-09-30 | $37.22M 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $25.25M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $22.94M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |